The company's main research directions:
(1) our own research and development and production of products, specializes in non-natural amino acids and their derivatives chiral synthesis technology research and production. To lacosamide and levetiracetam intermediates represented.
(2) our other partners developed the carrier hormone products and other pharmaceutical chemical intermediates.

Patent:
We focused on third-generation antiepileptic drug lacosamide has developed the first synthesis of chiral amino acids, and obtained a patent, has been completed in the trial, ready to enter the production stage.
2011, the application passes the two patents, the first patent is for the production of lacosamide third-generation antiepileptic drugs and intermediates negative step production process. The second is the use of a patented product lacosamide patented production methods and products.